The Bik gene is a member of the BH3-only proapoptotic subgroup (Certo et al., 2006; Suvarna et al., 2019) and has been proposed as an apoptosis-potentiating therapeutic gene in cancers (Zou et al., 2002). The gene discussed is BIK; the disease is cancer.